Apolipoprotein D is associated with long-term outcome in patients with schizophrenia.
Hansen T, Hemmingsen RP, Wang AG, Olsen L, Timm S, Søeby K, Jakobsen KD, Fenger M, Parnas J, Rasmussen HB, Werge T.
Hansen T, et al. Among authors: rasmussen hb.
Pharmacogenomics J. 2006 Mar-Apr;6(2):120-5. doi: 10.1038/sj.tpj.6500350.
Pharmacogenomics J. 2006.
PMID: 16402085